Gene expression profiling and subgroup identification of oligodendrogliomas

Oncogene

Volumn 23, Issue 35, 2004, Pages 6012-6022

  Huang, Hervé ^a   Okamoto, Yoshikazu ^a   Yokoo, Hideaki ^a   Heppner, Frank L ^b   Vital, Anne ^c   Fevre Montange, Michelle ^d   Jouvet, Anne ^d   Yonekawa, Yasuhiro ^e   Lazaridis, Emmanuel N ^a   Kleihues, Paul ^a   Ohgaki, Hiroko ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITÉ DE BORDEAUX   (France)

^d HÔPITAL NEUROLOGIQUE   (France)

^e UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

cDNA array; LOH 19q; LOH 1p; Low grade astrocytoma; Oligodendroglioma; TP53 mutations

Indexed keywords

4 AMINOBUTYRIC ACID; CALMODULIN; COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE; EPIDERMAL GROWTH FACTOR RECEPTOR; HISTONE H4; PROTEIN; PROTEIN P53; RHO FACTOR; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR JUND; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

AAD14 GENE; ARTICLE; ASTROCYTOMA; BRAIN BIOPSY; CDKN1A GENE; CONTROLLED STUDY; CYTOPLASM; GENE; GENE EXPRESSION; GENE IDENTIFICATION; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; ITGB4 GENE; NUCLEOTIDE SEQUENCE; OLIGODENDROGLIOMA; PCDH43 GENE; PRIORITY JOURNAL; RHO 7 GENE; RHOC GENE; SURVIVAL; TDGF1 GENE; WHITE MATTER; ADULT; BRAIN; BRAIN TUMOR; CLASSIFICATION; DISEASE COURSE; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENETICS; HETEROZYGOSITY LOSS; MALE; METABOLISM; MIDDLE AGED; MUTATION; TUMOR SUPPRESSOR GENE;

ADULT; ASTROCYTOMA; BRAIN; BRAIN NEOPLASMS; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION PROFILING; GENES, P53; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; MUTATION; OLIGODENDROGLIOMA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 4043072202     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207781     Document Type: Article

References (40)

1. Azzarelli BN, Miravalle LN and Vidal RN. (2003). J. Neuropathol. Exp. Neurol., 62, 544.
2. Blumcke I, Becker AJ, Normann S, Hans V, Riederer BM, Krajewski S, Wiestler OD and Reifenberger G. (2001). J. Neuropathol. Exp. Neurol., 60, 984-993.
3. Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR, Silver JS, Stark PC, Macdonald DR, Ino Y, Ramsay DA and Louis DN. (1998). J. Natl. Cancer Inst., 90, 1473-1479.
4. Durand JF, Roman S and Vivien M (eds) (2001). Guide d'utilisation de la Regression Partial Least Squares Lineaire sous Splus. Universite Montpellier II: Montpellier.
5. Fuller GN, Rhee CH, Hess KR, Caskey LS, Wang R, Bruner JM, Yung WK and Zhang W. (1999). Cancer Res., 59, 4228-4232.
6. Grifa A, Totaro A, Rommens JM, Carella M, Roetto A, Borgato L, Zelante L and Gasparini P. (1998). Biochem. Biophys. Res. Commun., 250, 240-245.
7. Gunthert AR, Grundker C, Hollmann K and Emons G. (2002). Biochem. Biophys. Res. Commun., 294, 11-15.
8. Gutmann DH, Hedrick NM, Li J, Nagarajan R, Perry A and Watson MA. (2002). Cancer Res., 62, 2085-2091.
9. Hall A. (1998). Science, 279, 509-514.
10. Huang H, Colella S, Kurrer M, Yonekawa Y, Kleihues P and Ohgaki H. (2000). Cancer Res., 60, 6868-6874.
11. Ino Y, Betensky RA, Zlatescu MC, Sasaki H, Macdonald DR, Stemmer-Rachamimov AO, Ramsay DA, Cairncross JG and Louis DN. (2001). Clin. Cancer Res., 7, 839-845.
12. Kleihues P, Davis RL, Ohgaki H, Burger PC, Westphal MM and Cavenee WK. (2000). Diffuse astrocytoma Pathology and Genetics of Tumours of the Nervous System, Kleihues P and Cavenee WK (eds). IARC Press: Lyon, pp. 22-26.
13. Li T, Dai W and Lu L. (2002). J. Biol. Chem., 277, 32668-32676.
14. Ligon KL, Alberta JA, Louis DN, Stiles CD and Rowitch DH. (2003). J. Neuropathol. Exp. Neurol., 62, 544.
15. Lu QR, Park JK, Noll E, Chan JA, Alberta J, Yuk D, Alzamora MG, Louis DN, Stiles CD, Rowitch DH and Black PM. (2001). Proc. Natl. Acad. Sci. USA, 98, 10851-10856.
16. Marie Y, Sanson M, Mokhtari K, Leuraud P, Kujas M, Delattre JY, Poirier J, Zalc B and Hoang-Xuan K. (2001). Lancet, 358, 298-300.
17. Markert JM, Fuller CM, Gillespie GY, Bubien JK, McLean LA, Hong RL, Lee K, Gullans SR, Mapstone TB and Benos DJ. (2001). Physiol. Genomics, 5, 21-33.
18. Miettinen HE, Paunu N, Rantala I, Kalimo H, Paljarvi L, Helin H and Haapasalo H. (2001). J. Neurooncol., 55, 29-37.
19. Mukasa A, Ueki K, Matsumoto S, Tsutsumi S, Nishikawa R, Fujimaki T, Asai A, Kirino T and Aburatani H. (2002). Oncogene, 21, 3961-3968.
20. Nguyen DV and Rocke DM. (2002). Bioinformatics, 18, 39-50.
21. Nigro JM, Takahashi MA, Ginzinger DG, Law M, Passe S, Jenkins RB and Aldape K. (2001). Am. J. Pathol., 158, 1253-1262.
22. Nutt CL, Mani DR, Betensky RA, Tamayo P, Cairncross JG, Ladd C, Pohl U, Hartmann C, McLaughlin ME, Batchelor TT, Black PM, von Deimling A, Pomeroy SL, Golub TR and Louis DN. (2003). Cancer Res., 63, 1602-1607.
23. Obata S, Sago H, Mori N, Rochelle JM, Seldin MF, Davidson M, St John T, Taketani S and Suzuki ST. (1995). J. Cell. Sci., 108 (Part 12), 3765-3773.
24. Ohnishi A, Sawa H, Tsuda M, Sawamura Y, Itoh T, Iwasaki Y and Nagashima K. (2003). J. Neuropathol. Exp. Neurol., 62, 1052-1059.
25. Perry JR. (2001). Curr. Opin. Neurol., 14, 705-710.
26. Peters HC, Kammer G, Volz A, Kaupmann K, Ziegler A, Bettler B, Epplen JT, Sander T and Riess O. (1998). Neurogenetics, 2, 47-54.
27. Reifenberger G, Kros JM, Burger PC, Louis DN and Collins VP. (2000). Oligodendroglioma Pathology and Genetics of Tumours of the Nervous System, Kleihues P and Cavenee WK (eds). IARC Press: Lyon, pp. 56-61.
28. Reifenberger J, Reifenberger G, Liu L, James CD, Wechsler W and Collins VP. (1994). Am. J. Pathol., 145, 1175-1190.
29. Rickman DS, Bobek MP, Misek DE, Kuick R, Blaivas M, Kurnit DM, Taylor J and Hanash SM. (2001). Cancer Res., 61, 6885-6891.
30. Sallinen SL, Sallinen PK, Haapasalo HK, Helin HJ, Helen PT, Schraml P, Kallioniemi OP and Kononen J. (2000). Cancer Res., 60, 6617-6622.
31. Sano K, Tanihara H, Heimark RL, Obata S, Davidson M, St John T, Taketani S and Suzuki S. (1993). EMBO J., 12, 2249-2256.
32. Schafer JL (ed) (1997). Analysis of Incomplete Multivariate Date. Chapman & Hall: London.
33. Smith JS, Perry A, Borell TJ, Lee HK, O'Fallon J, Hosek SM, Kimmel D, Yates A, Burger PC, Scheithauer BW and Jenkins RB. (2000). J. Clin. Oncol., 18, 636-645.
34. Tanwar MK, Gilbert MR and Holland EC. (2002). Cancer Res., 62, 4364-4368.
35. Vogt PK. (2001). Oncogene, 20, 2365-2377.
36. Wagner EF. (2001). Oncogene, 20, 2334-2335.
37. Watanabe K, Tachibana O, Sato K, Yonekawa Y, Kleihues P and Ohgaki H. (1996). Brain Pathol., 6, 217-224.
38. Watanabe T, Nakamura M, Kros JM, Burkhard C, Yonekawa Y, Kleihues P and Ohgaki H. (2001). Acta Neuropathol., 103, 267-275.
39. Watson MA, Perry A, Budhjara V, Hicks C, Shannon WD and Rich KM. (2001). Cancer Res., 61, 1825-1829.
40. Zerbini LF, Wang Y, Cho JY and Libermann TA. (2003). Cancer Res., 63, 2206-2215.